Event Content

Setting the Stage – AI Investment and Applications in the Life Sciences

There continues to be strong interest within the life science and healthcare industries on innovations that can yield new actionable insights and improve operational efficiencies. With a full spectrum of validated applications spanning multiple industries, AI promises to deliver new capabilities...

Qrativ Interview: Using AI for drug discovery without spending MORE billions

In an all-new podcast, Daniel Faggella talks to Murali Aravamudan, Founder and CEO of AI-driven drug discovery startup Qrativ, a joint venture by the Mayo Clinic and biotech/data science firm nference. Murali and Daniel discuss the surge of medical information...